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Purpose: The authors evaluated the impact of acute exercise and 24-hour recovery on serum concentration of cardiac troponins
T and I (cTnT and cTnI) and N-terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) in healthy children
and adolescents. The authors also determined the proportion of participants exceeding the upper reference limits and acute
myocardial infarction cutoff for each assay. Method: Web of Science, SPORTDiscus, MEDLINE, ScienceDirect, and Scopus
databases were systematically searched up to November 2017. Studies were screened and quality-assessed; the data was
systematically extracted and analyzed. Results: From 751 studies initially identiﬁed, 14 met the inclusion criteria for data
extraction. All 3 biomarkers were increased signiﬁcantly after exercise. A decrease from postexercise to 24 hours was noted in
cTnT and cTnI, although this decrease was only statistically signiﬁcant for cTnT. The upper reference limit was exceeded by 76%
of participants for cTnT, a 51% for cTnI, and a 13% for NT-proBNP. Furthermore, the cutoff value for acute myocardial
infarction was exceeded by 39% for cTnT and a 11% for cTnI. Postexercise peak values of cTnT were associated with duration
and intensity (Q(3) = 28.3, P < .001) while NT-proBNP peak values were associated with duration (Q(2) = 11.9, P = .003).
Conclusion: Exercise results in the appearance of elevated levels of cTnT, cTnI, and NT-proBNP in children and adolescents.
Postexercise elevations of cTnT and NT-proBNP are associated with exercise duration and intensity.
Keywords: sport medicine, cTnT, cTnI, NT-proBNP
Cardiac troponins T and I (cTnT and cTnI) are accepted
indicators of myocyte necrosis and are considered sensitive mar-
kers of myocardial injury (MI) and acute myocardial infarction
(AMI) (74). Serum cTnT and cTnI are elevated after irreversible
heart muscle damage and levels peak during the subsequent days
(1,59). The N-terminal fragment of the prohormone brain natri-
uretic peptide (NT-proBNP) is a marker accepted to reﬂect myo-
cardial stretch (73), which is currently used to detect heart failure
and asymptomatic left ventricular dysfunction (14,52) with the
magnitude and duration of release dependent on the severity of
stretch and stress (3).
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The lower detection limits of cTnT and cTnI assays have
been greatly reduced in recent years (58) with new high-sensitivity
assays available for both biomarkers. These assays can detect
the 99th percentile with a coefﬁcient of variation <10% and
measure cTn concentrations in at least a 50% of a healthy popula-
tion at rest (58). Although the higher sensitivity of these assays
enables better rates of true positive detection (40), a decline in
speciﬁcity has been reported such that cTn appearance might be
related to etiologies other than AMI (1,16,40). This can include
physical exercise as a known nonpathological cause of cTn
increase (1).
Numerous investigations have described the serological
release of cTnT, cTnI, and NT-proBNP after physical exercise
and its kinetics (15,22,60). Contrary to an AMI-related release, cTn
values normally peak within 2 to 5 (cTnT) and 3 to 6 (cTnI) hours
of postexercise and then decrease returning to basal levels after
24 hours of recovery in most participants (15,25). The differences
between cTnT and cTnI peaks might be related to differences in
their molecular weights (11). NT-proBNP release normally peaks
immediately after exercise and remains elevated during the subse-
quent 72 hours, and its clearance, which seems to take longer than
cTn, has been related to a temporary reduction in kidney function
subsequent to exercise (7,11). These observations have important
clinical implications, since the elevation of these cardiac bio-
markers for several hours after physical exercise might be mis-
interpreted in physically active patients, who are admitted to the
emergency department for chest pain of origins other than acute
coronary syndrome and heart failure.
The 99th percentile of a normal reference population, consid-
ered the upper reference limit (URL), is designated as the decision
level for the diagnosis of MI for both general and pediatrics
populations (34,74). In this respect, the reported 99th percentiles
for children are lower than in adults for cTn and NT-proBNP
(17,26,50), and both are used for clinical diagnostic (24). The
magnitude of cTn and NT-proBNP postexercise release, as well as
the prevalence of data above clinical cutoffs, have been extensively
studied in healthy adults. Only a limited number of studies
addressing the cardiac biomarker response to exercise in children
and adolescents are currently available. Moreover, these studies are
heterogeneous in terms of exercise exposure and often occur with
small sample sizes and thus a limited statistical power. As a result,
the association of cTn and NT-proBNP with exercise is currently
controversial (8,29,44,51,63,64,66,69) and might be confounded
with either individual as well as exercise characteristics.
Based on studies with adult participants, other individual
characteristics except age might inﬂuence cardiac biomarkers
release. Sex differences in cTn and NT-proBNP are controversial
(4,6,10,23,30,36,55,80). Previous exercise experience has been
negatively associated with cTn release (10,21,46,76) while training
load might be not associated with biomarker appearance (18,21,
28,33,67,78). NT-proBNP is not associated with previous exercise
experience either (62,67,75) while its association with training load
remains controversial (18,28,43,61–64,67). Finally, ﬁtness condi-
tion has not been associated with cTn or NT-proBNP data (67,70).
Exercise characteristics have also been studied as to their inﬂuence
on cardiac biomarker release (15,68). Exercise intensity was men-
tioned as a predictor for cTn release while exercise duration has
been correlated with both cTn and NT-proBNP data (9,7,12,61,
67,83). Exercise mode and type have not been fully evaluated, and
any associations remain controversial (32,53,85).
Previous systematic reviews and meta-analyses related to
cardiac biomarker release after exercise have been focused on
adult participants (15,65,68,82). To the best our knowledge, no
systematic review or meta-analysis has been published addressing
the cardiac biomarkers response to exercise in children and
adolescents. Considering that children and adolescents have a
low cardiovascular risk (2), we selected this special group to get a
“clean” background and preclude the potential effects of con-
cealed cardiovascular diseases and get “pure” effect of exercise on
cardiac biomarkers. Due to variations in sample size and the
diversity of participant and exercise characteristics, a systematic
review with a meta-analysis could contribute to the current
knowledge by synthesizing available data into single, more
powerful estimates of effect. Moreover, the secondary analysis
might help to identify possible associations with individual and
exercise characteristics that could explain a certain degree of
heterogeneity between the current ﬁndings.
In accordance with the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) Statement (41), the
main objective of this study was to systematically review studies
whose participants were healthy children and adolescents who
were exposed to physical exercise and whose resting and postex-
ercise measures of cTnT, cTnI, and NT-proBNP were described. A
secondary objective was to analyze the moderator effects of (1) age,
(2) pubertal status, (3) sex, (4) previous training (y), (5) current
training (in hours per week or kilometers per week), (6) exercise
duration (in minutes), (7) exercise intensity (average HR), (8) max-
imum oxygen uptake (VO2max), and (9) exercise mode on the
pooled effects determined by the main objective.
Methods
Search Strategy
We searched Web of Science, SPORTDiscus, MEDLINE,
ScienceDirect, and Scopus databases between July 1, 2017 and
November 30, 2017. A 3-component additive search key (#A AND
#B AND #C) was used with: #A, measurement; #B, intervention;
and #C, population. All searches were restricted to title or abstract,
and keywords were stated in English. The measurement was
deﬁned with the expression “cardiac biomarker*” OR Troponin
OR TnT OR TnI OR cTn* OR hs-cTn* OR “N-terminal prohor-
mone of brain natriuretic peptide” OR “NT-proBNP” OR
“NT-pro-BNP”. Intervention was speciﬁed with: exercise
OR sport* OR “physical activity” OR running OR marathon
OR soccer OR swim* OR athletes. Finally, the population was
stated with “children OR adolescent* OR young”.
Inclusion and Exclusion Criteria
We selected observational or experimental studies with a repeated
measures design. Participants (or a subset of them) must be under
the age of 18, not have a personal history or clinical evidences
of cardiovascular disease, and have a normal 12-lead electro-
cardiogram and/or echocardiogram at rest (71). Interventions of
interest were those which involved exposure to physical exercise,
including sport events and laboratory tests. We searched primarily
for studies that reported cTnT and/or cTnI and/or NT-proBNP
concentrations before and after exercise. Inclusion criteria
included the necessity to report some quantitative measure of
location and variation (mean [SD], median with range, or median
with interquartile range) of the biomarker’s value for a mini-
mum of one time point postintervention. Studies, where partici-
pants were exposed to speciﬁc pharmacological or nutritional
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interventions, were excluded and the remaining articles were
included in our review.
Data Extraction
Studies were inspected to gather the data for (where available):
sample size, sex, maturational status, age, training status (years
of previous experience, weekly hours of training, and weekly
kilometers of training); VO2max; performed exercise; exposure
duration (in minutes); average heart rate (surrogate of intensity);
and absolute concentration of cTnT, cTnI, or NT-proBNP before
and after exercise. We also recorded the proportion of participants
above the URL for each biomarker, and the rate of participants
above the cutoff for AMI for cTnT and cTnI. Outcomes reported as
median [range] were transformed to mean (SD) using Wan et al.
(84) formulas. All concentrations were expressed in nanograms
per liter (74), and concentrations of cTn reported as “under limits
of detection of 10 ng/L” were represented as 5 ng/L (12,48).
Quality Assessment
We analyzed the methodological quality of studies that met all
inclusion criteria to detect possible methodological discrepancies
that might explain a degree of heterogeneity between studies. In
this sense, studies’ quality was assessed by 2 authors indepen-
dently, ﬁlling the Quality Assessment Tool for before–after (Pre–
Post) studies with no control group from the National Heart Lung
and Blood Institute (42). This scale considers 12 binary items,
which average scores of each article from 0 indicating high risk of
bias to 1 indicating low risk of bias (QATi). Discrepancies between
assessors were resolved by a third author.
Statistical Analysis
All analyses were performed in R (R Foundation for Statistical
Computing, Vienna, Austria; 54) using Viechtbauer’s “metafor”
package v 1.9-9 (81). Random effects meta-analyses were con-
ducted by biomarker (cTnT, cTnI, and NT-proBNP) using the
following estimates: the baseline concentration, the peak concen-
tration, the concentration at 24 hours, the absolute mean differ-
ence between baseline and peak concentrations, the absolute
mean difference between baseline and concentration after
24-hours recovery, the absolute mean difference between peak
concentrations and concentrations at 24-hour postexercise, the
rate of participants whose peak concentration exceeded the assay
URL, and the rate of participants exceeding the cutoff for AMI.
Rates were log-transformed for statistical comparisons, and es-
timates were then back-transformed for ease of interpretation.
Heterogeneity was measured with Cochrane’s Q statistic and I2
values (19). We assessed publication bias using Egger’s regres-
sion test for funnel plot asymmetry (5,56). Subgroup analyses
were conducted when heterogeneity was signiﬁcant to assess the
possible inﬂuence of exercise mode, age, intensity, and duration
on the absolute mean difference between baseline and peak
concentrations. In addition, when data was available, we investi-
gated for the possible inﬂuence of Tanner stage, sex, VO2max,
years of previous training, weekly hours of training, and weekly
kilometers of training, regardless of exercise mode, age, intensity,
and duration. Outcome multiplicity from the same groups (12)
was controlled introducing a study identiﬁed as a random effect
(79,81). Measures are expressed as mean ± 95% conﬁdence inter-
vals (CI) unless otherwise stated, and we considered statistically
signiﬁcant differences when P < .05.
Results
The search process is outlined in Figure 1. Fourteen studies met the
inclusion/exclusion criteria that included 21 groups covering a total
sample of 336 participants (72 females) who had a mean age of
15.1 (2.3) years (12,13,20,27,30,38,39,46–49,75–77). Two studies
provided complete data from more than 1 subgroup contributing
with different estimates by sex (27,77) or Tanner stage (30), which
were treated as different units for the analysis. One study provided
4 outcome measurements from the same group at different ex-
posures (12), which were controlled for multiplicity within the
models (79,81). Interventions were based on 5 different modalities:
in 9 studies, participants ran [3 treadmill protocols [45–90 min]
(13,47,75); 5 half marathons (12,27,46,48,76); and 1 full marathon
(77)]; in 2 studies, basketball was employed (38,49); in 1 study, a
soccer match was played (20); in 1 study, participants swam for
60 min (30); and 1 study included a set of table tennis exercises
(39). Table 1 shows the number of groups available for each
comparison (k) as well as their respective pooled effect sizes.
Quality Assessment and Risk of Publication Bias
Studies had a mean quality score of .61 (.07). Prespeciﬁcation of
sample eligibility criteria, enrollment of all eligible participants and
sample size calculation were rated as high risks of bias in all
studies. Other concurrent items rated as high risk of bias were
blinding of outcome assessors; controlling for confounding vari-
ables in the statistical analysis; reporting the main effect of time
with P values; and validity and reliability of outcome measures in
12, 9, 3, and 1 cases, respectively. On the other hand, Egger’s
Figure 1 — Flowchart for study inclusion and exclusion stages.
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regression test was signiﬁcant for all 3 biomarkers cTnT, cTnI, and
NT-proBNP (P < .001), suggesting that current literature was still
unrepresentative of the population of completed studies.
Cardiac Troponin T
Participants had an overall cTnT concentration at baseline of 5 ng/L
(4–6 ng/L). This concentration was increased (P < .001) after 2 to
5 hours, reaching a peak of 144 ng/L (83–205 ng/L). Finally,
24 hours after exercise, cTnT was reduced (P < .002) with a pooled
concentration of 11 ng/L (5–16 ng/L), which was slightly higher
than at baseline (P = .01) (Figure 1). All 3 pooled concentrations,
as well as their differences, were heterogeneous between studies
(P < .001 in all comparisons). Overall, 76% (66%–87%, P < .001)
of participants had a cTnT peak above the assays URL, and a
39% (26%–60%, P < .001) exceeded the cutoff for AMI. Again,
both rates, for MI and for AMI, were heterogeneous between
studies (P = .047 and P < .001, respectively).
In the subgroups analyses, cTnT was measured in 4 exercise
modes, namely half marathon, treadmill running, table tennis, and
swimming. Exercise mode, available in k = 14 units with a total of
n = 193 participants, had a main effect on cTnT increase to peak
(Q(3) = 9.98, P = .02). Post hoc analysis revealed that after a half
marathon and treadmill run cTnT increases were higher than after
intermittent table tennis and swimming (P < .001 and P = .004,
respectively). Multiple regression with exercise mode as a random
effect (k = 11, n = 138), revealed that age had a negative association
(P < .001) while intensity and duration were positively associated
(P < .001 and P = .003, respectively) with cTnT increase (Q(3) =
28.3, P < .001). Moreover, participants’ VO2max correlated nega-
tively with cTnT increase (k = 7, n = 60, P = .04). We did not ﬁnd
associations between cTnT increase and sex (k = 11, n = 138,
P = .3), Tanner stage (k = 4, n = 63, P = .504); years of previous
training (P = .16); or weekly kilometers of training (k = 10, n =110,
P = .32).
Cardiac Troponins I
The pooled baseline concentration for cTnI was 16 ng/L (10–
22 ng/L). After 3 to 6 hours of exercise exposure, participants
increased this concentration (P = .04) up to a peak of 248 ng/L
(17–478 ng/L). After 24-hour recovery, this reduced to 38 ng/L
(19–56 ng/L) which was not statistically different from the estimated
peak concentration (P = .06) (Figure 2). However, all 3 pooled
concentrations, as well as their differences, were heterogeneous
between studies (P < .001 in all comparisons). The proportion of
participants with cTnI above the URL was 51% (32%–81%) and the
rate exceeding the cutoff for AMI was 11% (5%–24%). The rate for
Table 1 Estimated Pooled Effect Sizes (95% CI) by Biomarker
k Pooled effect size Z P(Z) Q P(Q) I
2, %
Cardiac troponin T
Mean baseline, ng/L 16 5 (4 to 6) 11.84 <.001 206.47 <.001 98.7
Mean peak, ng/L 14 144 (83 to 205) 4.65 <.001 105.78 <.001 96.5
Mean at 24 h, ng/L 9 11 (5 to 16) 3.86 <.001 146.52 <.001 98.2
Dif. peak–pre, ng/L 14 139 (79 to 198) 4.53 <.001 102.72 <.001 96.4
Dif. 24 h–peak, ng/L 7 −89 (–147 to –32) −3.04 .002 33.85 <.001 93
Dif. 24 h–pre, ng/L 9 7 (1 to 12) 2.5 .01 87.22 <.001 96.3
MI threshold IR 18 0.76 (0.66 to 0.87) −3.83 <.001 27.86 .047 13.5
AMI threshold IR 14 0.39 (0.26 to 0.6) −4.38 <.001 39.1 <.001 75.4
Cardiac troponin I
Mean baseline, ng/L 7 16 (10 to 22) 5.15 <.001 89.67 <.001 96.4
Mean peak, ng/L 5 248 (17 to 478) 2.1 .04 61.42 <.001 99
Mean at 24 h, ng/L 7 38 (19 to 56) 4.05 <.001 348.01 <.001 97.7
Dif. peak–pre, ng/L 5 228 (6 to 450) 2.01 .04 54.53 <.001 98.9
Dif. 24 h–peak, ng/L 5 −199 (–404 to 5) −1.91 .06 42.56 <.001 98.2
Dif. 24 h–pre, ng/L 7 21 (8 to 33) 3.23 .001 100.97 <.001 93.2
MI threshold IR 7 0.51 (0.32 to 0.81) −2.85 .004 16.74 .01 60.5
AMI threshold IR 4 0.11 (0.05 to 0.24) −5.4 <.001 3.41 .33 24.4
NT-proBNP
Mean baseline, ng/L 6 77 (14 to 140) 2.38 .02 217.98 <.001 99.5
Mean peak, ng/L 6 106 (17 to 195) 2.34 .02 288.19 <.001 99.5
Mean at 24 h, ng/L 4 83 (0a to 182) 1.63 .10 173.89 <.001 99.6
Dif. peak–pre, ng/L 6 20 (2 to 38) 2.20 .03 13.64 .02 79.2
Dif. 24 h–peak, ng/L 4 −2 (–11 to 7) −0.48 .63 7.26 .06 0.1
Dif. 24 h–pre, ng/L 4 4 (–8 to 28) 1.55 .44 0.65 .88 0
MI threshold IR 6 0.13 (0.04 to 0.44) −3.32 <.001 18.02 .003 74.1
Abbreviations: AMI, acute myocardial infarction; CI, conﬁdence interval; Dif., difference; IR, incidence rates; MI, myocardial injury; NT-proBNP, N-terminal fragment
of the prohormone brain natriuretic peptide. Note: Estimated effects for IR were back transformed for easier interpretation.
aMathematically negative and truncated to 0 avoiding values outside the parameter space.
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MI was heterogeneous (P = .01) while the rate for AMI was not
(P = .33) between individual studies.
In the subgroup analysis, cTnI was measured in 4 exercise
modes, namely half marathon, basketball, table tennis, and soccer.
The cTnI increase to peak did not differ between exercise modes
(k = 5, n = 83, Q(4) = 4.75, P = .31); multiple comparisons (k = 4,
n = 61) at different ages (P = .33); intensities (P = .59); or durations
(P = .31). In addition, we did not ﬁnd differences due to years of
training (k = 3, n = 33, P = .37) or participants’ VO2max (k = 3,
n = 33, P = .54). Tanner stage and weekly training load data were
not available to be modeled.
N-Terminal Prohormone Brain Natriuretic Peptide
The pooled baseline concentration for NT-proBNP corresponded
to 77 ng/L (14–140 ng/L). This concentration was increased imme-
diately after exercise (P = .03) achieving a peak of 106 ng/L
(17–195 ng/L). Finally, 24 hours after exercise, NT-proBNP con-
centration did not differ from its peak (P = .63) or baseline (P = .44)
with an estimate of 83 ng/L (0–182 ng/L) (Figure 2). All 3
concentrations were heterogeneous (P < .001). The rate of partici-
pants with NT-proBNP concentration above the URL was 13%
(4%–44%, P < .001), and studies were heterogeneous (P = .003).
In the subgroup analysis, NT-proBNP was present in 4
different exercise modes, namely half marathon, treadmill running,
swimming, and soccer. Exercise mode had a main effect on the
NT-proBNP postexercise increase (k = 6, n = 101, Q(4) = 25.06,
P < .001). Post hoc comparisons revealed that the higher NT-
proBNP increases were related with soccer (estimated increase
of 83 ng/L, 95% CI, 34–131 ng/L; P < .05) followed by half
marathon (estimated increase of 59 ng/L, 95% CI, 12–105 ng/L;
P = .01) and ﬁnally followed by swimming (estimated increase of
11 ng/L, 95% CI, 3–18 ng/L; P = .01), with no differences in the
mode of treadmill running (P = .93). Moreover, in a multiple
regression with exercise mode as a random effect (k = 4, n = 62),
duration had a positive association with the estimate (P < .001)
while age (P = .34) and intensity (P = .37) were not associated with
NT-proBNP (Q(2) = 11.9, P = .003). Finally, we did not ﬁnd differ-
ences in NT-proBNP for sex (k = 4, n = 62, P = .3); Tanner stage
(k = 3, n = 50, P = .601); and years of previous training (k = 4,
n = 62, P = .499). VO2max and weekly training load data were not
available to be modeled.
Discussion
The main purpose of this systematic review and meta-analysis was
to estimate how exercise modulated the blood concentration of
cTnT, cTnI, and NT-proBNP in children and adolescents. Overall,
this review found: (1) all 3 biomarkers were signiﬁcantly elevated
after exercise; (2) a decrease from peak values after 24-hour
recovery was only signiﬁcant for cTnT; (3) the rate of participants
exceeding the biomarkers’URLwere 76% for cTnT, 51% for cTnI,
and 13% for NT-proBNP; (4) the rate of participants exceeding the
cutoff value for AMI were 39% for cTnT and 11% for cTnI;
(5) individual variability was observed between studies; and
(6) exercise duration inﬂuenced both cTnT and NT-proBNP while
intensity inﬂuenced only cTnT. Despite these ﬁndings, the quality
assessment of studies together with the analysis for publication bias
revealed that current studies have a fair degree of quality with
limited bias.
Cardiac Troponins T and I
Our results indicate that cTn release in children and adolescents is
inherent to physical exercise. Data reﬂect a fast increase of cTnT
during the early hours of recovery, with close to complete recovery
to baseline at 24 hours. Similar results were appreciable for cTnI,
although statistical power was limited and lead to only marginally
signiﬁcant differences between peak and 24-hour values. Such
observations suggest that cTn kinetics in children and adolescents
during a 24-hour recovery are comparable with the observed in
adults (15,25). Our results coincide with previous research observ-
ing the highest cTnT and cTnI concentrations about 2 to 3 and 3 to
5 hours postexercise, respectively (15,25). Based upon the previous
text, when repeated blood sampling is not possible, single samples
taken within such interval might detect concentrations close to the
kinetics peak.
The current data suggest that, as in the case of adults (32,33),
there is a marked individual variability regarding the exercise-
induced release of cTn, with a high proportion of participants with
values exceeding the URL for MI and AMI. As evidenced in
controlled studies with adolescents (12) and adults (67), cTnT
variability could be partially explained by exercise intensity and
duration, what likely reﬂects an impact of exercise volume on
cardiac work. We also observed a higher cTnT release in the
younger participants, and this could explain that the proportion of
participants exceeding the URL in our study is higher than the
reported by a recent meta-analysis without age restrictions (65).
This would suggest a role for maturity mediating the postexercise
cTn release. However, direct comparisons of the release of cTn
Figure 2 — Estimated kinetics by biomarker before, at peak value, and
24 hours after exercise, with their 95% conﬁdence interval, respectively.
cTnT indicates cardiac troponin T; cTnI, cardiac troponin I; NT-proBNP,
N-terminal fragment of the prohormone brain natriuretic peptide. Note:
a = signiﬁcant increase; b = signiﬁcant decrease; and c = higher than at
baseline.
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after exercise in adults and adolescents have disclosed contradic-
tory ﬁndings (30,38,75). Moreover, with the scarce data currently
available, we did not ﬁnd any association between cTnT release
and pubertal status. At all events, associations with pubertal status
require further investigation. Running seems to induce higher
cTnT releases than other modes as it was noticed in a previous
meta-analysis based on adult participants (68); nevertheless, such
an assertion is complex to verify through direct comparisons.
Although we observed lower cTnT releases in participants with
greater VO2max, we could not corroborate whether the cTnT
increase is mediated by current training or training history. It
was not evident whether there were any sex differences in the
cTn release. This coincides with previous studies in adults which
reported a limited inﬂuence of sex and training history on the
release of cTn (4,27,30,32,33,38,77). The scarce number of studies
did not allow to explain the between-subjects variability regarding
the release of cTnI.
N-Terminal Prohormone Brain Natriuretic Peptide
An increase in NT-proBNP immediately after exercise was con-
ﬁrmed without a signiﬁcant reduction within the 24-hour recovery
period that supports past research with adults (31,37). NT-proBNP
may have a longer clearance period that cTn possibly extended to
72 hours (7,11). In this regard, it has been suggested that BNP may
play an important role in homeostasis during the transition of the
circulation from children to maturity as a marker of myocardial
growth (72). This might reﬂect an early myocardial adaptation to
the intense training stimulus in children and adolescents. In either
case, these possibilities require further study.
We noted that NT-proBNP changes with exercise were lower
than the observed in cTn. Therefore, the proportion of participants
exceeding the URL of NT-proBNP was lower than the reported
in studies with adults (11,60). These differences might be associ-
ated with age. However, neither our analysis nor previous studies
comparing directly adolescents with adults found NT-proBNP
differences for age and pubertal status (30,75). It is therefore
plausible to think that these differences might be related to
exercises with less duration in studies conducted with adolescents
compared with their equivalents with adults. Our results conﬁrm
indeed that in adolescents the release of NT-proBNP is largely
associated with exercise duration, as it was reported previously in
studies with adults (66,67). Given the close relationship between
preexercise and postexercise values (31,33), baseline differences
between studies might explain part of the differences we observed
across NT-proBNP peak values depending on the exercise mode.
Our results also conﬁrmed that as in adults (4,30,31,33,66,67)
exercise intensity, training, ﬁtness, and sex have limited inﬂuence
on the release of NT-proBNP with exercise.
Clinical Implications
A cardiac biomarker release was observed in most of the partici-
pants in all included studies, despite a certain degree of between-
study variability. Importantly, this analysis shows that in children
and adolescents, the factors mediating cardiac biomarkers after
exercise as well as their kinetics, are comparable with the observed
in previous studies in adults and differ from the observed after MI
and AMI (73,74). It has been suggested that this reﬂects a reversible
cellular process triggered by a normal physiological response to
exercise (7,45,57,62). Likewise, the increase of cTn might reﬂect
an increased rate and force of cardiac contraction during exercise
that causes transient membrane damage and enables cytosolic cTn
to pass into circulation (69). On the other hand, a release of
NT-proBNP from the ventricular cardiomyocytes might reﬂect a
volume overload and cardiac wall stretch during exercise (11).
Furthermore, some authors suggested that the use of the general
population values as a reference might not be appropriate for adult
athletes being evaluated for medical conditions using blood indices
of cardiac biomarkers. This has prompted the reﬂection that cardiac
biomarkers values might be stratiﬁed according to the physical
activity of the adult subjects for improving the clinical usefulness
of the biomarker (35). In this sense, our analysis extends this to
children and adolescents and suggests that when evaluating cTnT,
cTnI, and NT-proBNP in emergency settings, detailed information
regarding any recent exercise should be obtained (38).
Limitations
The main limitation of this systematic review and meta-analysis
derives from the incomplete data provided by a range of heteroge-
neous studies. Moderator analyses were performed with reduced
numbers that decreased statistical power. This lack of statistical
power might explain some nonsigniﬁcant results such as the
inconclusive decrease in cTnI within a 24-hour postexercise recov-
ery. We did not incorporate assay precision to our meta-analysis
which could have explained certain degree of the study-to-study
heterogeneity (68). Finally, we found differences between studies
regarding when peak concentrations were taken or noted. More
research should be conducted with children and adolescents ana-
lyzing such covariate parameters.
Conclusion
Cardiac biomarkers in children and adolescents are signiﬁcantly
increased from rest to postexercise with the URL exceeded by a
76% of participants for cTnT, a 51% for cTnI, and a 13% for
NT-proBNP, and the cutoff value for AMI is exceeded by 39%
for cTnT and an 11% for cTnI. Finally, we conﬁrmed that the
cTnT release is mainly associated with exercise duration and
intensity, while the NT-proBNP release remains inﬂuenced only
by exercise duration.
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